SIREN : 352027874
BIOQUAL is a French company founded 36 years ago, specialized in the sector Analyses, essais et inspections techniques. Based in PAMIERS (09100), this company of category PME shows in 2022 a revenue of 911 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | N/C | N/C | N/C | 910 867 € | 906 509 € | 789 162 € | 783 377 € | 758 576 € | 748 649 € |
| Net income | 55 722 € | 135 558 € | 100 835 € | 68 108 € | 64 910 € | 43 762 € | 65 218 € | 44 843 € | 33 025 € |
| EBITDA | N/C | N/C | N/C | 116 026 € | 117 879 € | 80 676 € | 109 614 € | 70 000 € | 67 148 € |
| Net margin | N/C | N/C | N/C | 7.5% | 7.2% | 5.5% | 8.3% | 5.9% | 4.4% |
In 2025, BIOQUAL generates positive net income of 56 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 33 k€ -> 56 k€.
55 722 €
The debt ratio (= Financial debt / Equity x 100) stands at 11%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
11.083%
64.561%
50.5%
In 2025, the debt ratio of BIOQUAL (11.08) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2025, the financial autonomy of BIOQUAL (64.6%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.
The liquidity ratio (= Current assets / Current liabilities) stands at 271.45. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
271.45
In 2025, the liquidity ratio of BIOQUAL (271.45) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
0 €
0 j
0 j
0 j
Based on 53 transactions of similar company sales
in 2025,
the value of BIOQUAL is estimated at
162 647 €
(range 61 540€ - 402 506€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 53 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare BIOQUAL with other companies in the same sector:
Voir toutes les statistiques du secteur Analyses, essais et inspections techniques
The revenue of BIOQUAL in 2022 is 911 k€.
Yes, BIOQUAL generated a net profit of 56 k€ in 2025.
The headquarters of BIOQUAL is located in PAMIERS (09100), in the department Ariege.
The tax return of BIOQUAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
BIOQUAL operates in the sector Analyses, essais et inspections techniques (NAF code 71.20B). See the 'Sector positioning' section above to compare the company with its competitors.